Mercer Global Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Mercer Global Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,328	Closed	-$703K	–	2409
2025 Q1	$703K	Sell	5,328 -2,143	-29%	-$267K	﹤0.01%	1299
2024 Q4	$624K	Buy	+7,471	New	+$614K	﹤0.01%	1328

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mercer Global Advisors's ITCI Position: Q2 2025 in Review

Mercer Global Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 5,328 shares — an estimated $703K sold.

Mercer Global Advisors first reported a position in ITCI in Q4 2024 and held it in 2 quarters. The position peaked at $703K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Mercer Global Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Mercer Global Advisors sold 5,328 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $703K.
Mercer Global Advisors first reported a position in Intra-Cellular Therapies Inc. in Q4 2024 and held it in 2 quarters.
Mercer Global Advisors's Intra-Cellular Therapies Inc. position peaked at $703K in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Mercer Global Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.